Close Menu

NEW YORK – Mission Bio announced on Thursday that it has received a $2 million Small Business Innovation Research grant from the National Cancer Institute to develop a targeted sequencing panel to quantify minimal residual disease in acute myeloid leukemia.

The two-year grant, which was awarded Sept. 12 and is worth $1 million each year, will fund a partnership with researcher Jerald Radich of the Fred Hutchinson Cancer Research Center.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.